SecBot SecBot
SECBOTREPLAY Home › Report › KALA

KALA · KALA BIO received a delisting notice from Nasdaq on August 27, 2026,…

KALA BIO, Inc. · 8-K filed Aug 28, 2026 at 06:45 ET

At the news

BEARISHIMPACT 8/10

8-K filed Aug 28, 2026 at 06:45 ET

KALA BIO received a delisting notice from Nasdaq on August 27, 2026, because its stock closed below $1.00 for 30 consecutive business days. The company is ineligible for the standard 180-day compliance period because it already executed a 1-for-50 reverse stock split on May 11, 2026. KALA intends to appeal to a Nasdaq Hearings Panel, which will stay any suspension pending a decision, but the path to regaining compliance is highly uncertain given the company's distressed financial condition and recent massive ATM equity offering.

  • Nasdaq notified KALA on August 27, 2026 that its bid price was below $1.00 for 30 consecutive business days (July 16–August 26, 2026).
  • KALA is ineligible for the standard 180-day compliance period because it effected a 1-for-50 reverse stock split on May 11, 2026.
  • KALA intends to request a hearing before the Nasdaq Hearings Panel to appeal the delisting determination.
  • A timely hearing request will stay any suspension or delisting action pending the Panel's decision.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access